Thermo Fisher Scientific (TMO) Other Working Capital Changes (2019 - 2020)

Thermo Fisher Scientific has reported Other Working Capital Changes for 11 years, with the latest figure at $222.0 million in Q4 2019.

• Other Working Capital Changes for Q4 2020 came in at -$410.0 million, down 322.83% year-over-year; the trailing twelve-month figure through Dec 2020 was -$1.5 billion (down 833.33% YoY), and the FY2025 annual result was $1.3 billion, up 605.38% from the prior year.
• Other Working Capital Changes advanced to -$410.0 million in Q4 2020, from -$739.0 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $443.0 million in Q1 2020 and troughed at -$746.0 million in Q2 2020.
• A 5-year average of $45.7 million and a median of $45.4 million in 2016 frame the typical range for Other Working Capital Changes.
• The widest annual swing landed in 2015, when Other Working Capital Changes surged 995.24%; it then slumped 301.82% in 2018.
• A 2-year view of Other Working Capital Changes shows it stood at $184.0 million in 2019, then plunged by 322.83% to -$410.0 million in 2020.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$410.0 million in Q4 2020, -$739.0 million in Q3 2020, and -$746.0 million in Q2 2020.